North America Vascular Access Devices Market

North America Vascular Access Devices Market Size & Growth (2023 to 2028):

As per the research report, the size of the North America Vascular Access Devices Market was worth USD 1.80 billion in 2023 and is expected to reach USD 2.46 billion by 2028 registering a CAGR of 6.45% from 2023 to 2028.

The rising frequency of lifestyle diseases, growth in chemotherapy operations, and the increasing usage of vascular access devices in pediatric patients are key market drivers in the North American region. Blood transfusions are becoming more common, especially in this region. Patients demand central venous access during long-term intravenous therapy such as chemotherapy, and antimicrobial treatment is driving market expansion. Increase in government investment in healthcare infrastructure is likely to assist market development.

In addition, an increase in the number of occurrences of lifestyle-related disorders increased knowledge of preventive healthcare, and clinical studies for vascular access devices in the region are boosting the market growth. Cancer, renal failure, and heart disease are only a few of the leading chronic diseases. Several lifestyle disorders are associated with chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, that require acute treatment while in the hospital.

In addition, intravenous antibiotic therapy, extended intravenous nutritional support, and blood sample collection are becoming more familiar with vascular access procedures. As a result, various medical device businesses are likely to invest and launch new products, functioning as one of the market's primary drivers.

The cost of maintaining and implanting vascular access devices is relatively high, which may restrict the North American vascular access devices market's growth.

This research report on the North America Vascular Access Devices Market has been segmented and sub-segmented into the following categories:

By Type:

• Peripheral
• Central
• Accessories

By Application:

• Drug Administration
• Fluid & Nutrition Administration
• Blood Transfusion
• Diagnostics Testing

By End Users:

• Hospitals
• Clinics
• Ambulatory Care Centers
• Other End Users

By Country:

• U.S
• Canada
• Rest of North America

Geographically, the North American market was predicted to hold the highest share of the industry. The high frequency of cardiovascular disorders in the United States, an increase in cancer cases, and an increase in research contribute to this industry's significant share. Technological advancements in medical device development, together with an increase in the number of procedures performed that need modern medical equipment, are having a more significant impact on market growth.

Leading global companies are growing their presence in developing countries such as the US and Canada to take advantage of these countries' growth prospects. The frequency of end-stage renal disease (ESRD) is increasing at an alarming rate, resulting in chronic kidney disease. In 2019, over 35 million persons were diagnosed with chronic renal disease in the United States. The region's expansion is fueled by its established healthcare infrastructure, expanding cancer-related causes, and increased investments in research and clinical trials.

The United States vascular access devices market is mature and will decrease somewhat over the forecast period. Intense pricing pressures, which will result in dropping ASPs in most product sectors, will counteract rising unit sales, driven by an expanding patient pool in the United States.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Vascular Access Devices Market profiled in this report are Becton Dickinson and Company, C.R.Bard Inc, Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.,